Schizophrenia Increases Variability of the Central Antioxidant System: A Meta-Analysis of Variance From MRS Studies of Glutathione

Patients with schizophrenia diverge in their clinical trajectories. Such diverge outcomes may result from the resilience provided by antioxidant response system centered on glutathione (GSH). Proton Magnetic Resonance Spectroscopy (1H-MRS) has enabled the precise in vivo measurement of intracortical...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lena Palaniyappan, Priyadharshini Sabesan, Xuan Li, Qiang Luo
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/4016db6ba57142a8b9f70c2a2ea7aa1a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4016db6ba57142a8b9f70c2a2ea7aa1a
record_format dspace
spelling oai:doaj.org-article:4016db6ba57142a8b9f70c2a2ea7aa1a2021-12-01T15:49:03ZSchizophrenia Increases Variability of the Central Antioxidant System: A Meta-Analysis of Variance From MRS Studies of Glutathione1664-064010.3389/fpsyt.2021.796466https://doaj.org/article/4016db6ba57142a8b9f70c2a2ea7aa1a2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fpsyt.2021.796466/fullhttps://doaj.org/toc/1664-0640Patients with schizophrenia diverge in their clinical trajectories. Such diverge outcomes may result from the resilience provided by antioxidant response system centered on glutathione (GSH). Proton Magnetic Resonance Spectroscopy (1H-MRS) has enabled the precise in vivo measurement of intracortical GSH; but individual studies report highly variable results even when GSH levels are measured from the same brain region. This inconsistency could be due to the presence of distinct subgroups of schizophrenia with varying GSH-levels. At present, we do not know if schizophrenia increases the interindividual variability of intracortical GSH relative to matched healthy individuals. We reviewed all 1H-MRS GSH studies in schizophrenia focused on the Anterior Cingulate Cortex published until August 2021. We estimated the relative variability of ACC GSH levels in patients compared to control groups using the variability ratio (VR) and coefficient of variation ratio (CVR). The presence of schizophrenia significantly increases the variability of intracortical GSH in the ACC (logVR = 0.12; 95% CI: 0.03–0.21; log CVR = 0.15; 95% CI = 0.06–0.23). Insofar as increased within-group variability (heterogeneity) could result from the existence of subtypes, our results call for a careful examination of intracortical GSH distribution in schizophrenia to seek redox-deficient and redox-sufficient subgroups. An increase in GSH variability among patients also indicate that the within-group predictability of adaptive response to oxidative stress may be lower in schizophrenia. Uncovering the origins of this illness-related reduction in the redox system stability may provide novel treatment targets in schizophrenia.Lena PalaniyappanLena PalaniyappanLena PalaniyappanLena PalaniyappanPriyadharshini SabesanXuan LiQiang LuoQiang LuoFrontiers Media S.A.articlepsychosisredoxanterior cingulate (ACC)n-acetyl cysteine (NAC)Nrf2spectroscopyPsychiatryRC435-571ENFrontiers in Psychiatry, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic psychosis
redox
anterior cingulate (ACC)
n-acetyl cysteine (NAC)
Nrf2
spectroscopy
Psychiatry
RC435-571
spellingShingle psychosis
redox
anterior cingulate (ACC)
n-acetyl cysteine (NAC)
Nrf2
spectroscopy
Psychiatry
RC435-571
Lena Palaniyappan
Lena Palaniyappan
Lena Palaniyappan
Lena Palaniyappan
Priyadharshini Sabesan
Xuan Li
Qiang Luo
Qiang Luo
Schizophrenia Increases Variability of the Central Antioxidant System: A Meta-Analysis of Variance From MRS Studies of Glutathione
description Patients with schizophrenia diverge in their clinical trajectories. Such diverge outcomes may result from the resilience provided by antioxidant response system centered on glutathione (GSH). Proton Magnetic Resonance Spectroscopy (1H-MRS) has enabled the precise in vivo measurement of intracortical GSH; but individual studies report highly variable results even when GSH levels are measured from the same brain region. This inconsistency could be due to the presence of distinct subgroups of schizophrenia with varying GSH-levels. At present, we do not know if schizophrenia increases the interindividual variability of intracortical GSH relative to matched healthy individuals. We reviewed all 1H-MRS GSH studies in schizophrenia focused on the Anterior Cingulate Cortex published until August 2021. We estimated the relative variability of ACC GSH levels in patients compared to control groups using the variability ratio (VR) and coefficient of variation ratio (CVR). The presence of schizophrenia significantly increases the variability of intracortical GSH in the ACC (logVR = 0.12; 95% CI: 0.03–0.21; log CVR = 0.15; 95% CI = 0.06–0.23). Insofar as increased within-group variability (heterogeneity) could result from the existence of subtypes, our results call for a careful examination of intracortical GSH distribution in schizophrenia to seek redox-deficient and redox-sufficient subgroups. An increase in GSH variability among patients also indicate that the within-group predictability of adaptive response to oxidative stress may be lower in schizophrenia. Uncovering the origins of this illness-related reduction in the redox system stability may provide novel treatment targets in schizophrenia.
format article
author Lena Palaniyappan
Lena Palaniyappan
Lena Palaniyappan
Lena Palaniyappan
Priyadharshini Sabesan
Xuan Li
Qiang Luo
Qiang Luo
author_facet Lena Palaniyappan
Lena Palaniyappan
Lena Palaniyappan
Lena Palaniyappan
Priyadharshini Sabesan
Xuan Li
Qiang Luo
Qiang Luo
author_sort Lena Palaniyappan
title Schizophrenia Increases Variability of the Central Antioxidant System: A Meta-Analysis of Variance From MRS Studies of Glutathione
title_short Schizophrenia Increases Variability of the Central Antioxidant System: A Meta-Analysis of Variance From MRS Studies of Glutathione
title_full Schizophrenia Increases Variability of the Central Antioxidant System: A Meta-Analysis of Variance From MRS Studies of Glutathione
title_fullStr Schizophrenia Increases Variability of the Central Antioxidant System: A Meta-Analysis of Variance From MRS Studies of Glutathione
title_full_unstemmed Schizophrenia Increases Variability of the Central Antioxidant System: A Meta-Analysis of Variance From MRS Studies of Glutathione
title_sort schizophrenia increases variability of the central antioxidant system: a meta-analysis of variance from mrs studies of glutathione
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/4016db6ba57142a8b9f70c2a2ea7aa1a
work_keys_str_mv AT lenapalaniyappan schizophreniaincreasesvariabilityofthecentralantioxidantsystemametaanalysisofvariancefrommrsstudiesofglutathione
AT lenapalaniyappan schizophreniaincreasesvariabilityofthecentralantioxidantsystemametaanalysisofvariancefrommrsstudiesofglutathione
AT lenapalaniyappan schizophreniaincreasesvariabilityofthecentralantioxidantsystemametaanalysisofvariancefrommrsstudiesofglutathione
AT lenapalaniyappan schizophreniaincreasesvariabilityofthecentralantioxidantsystemametaanalysisofvariancefrommrsstudiesofglutathione
AT priyadharshinisabesan schizophreniaincreasesvariabilityofthecentralantioxidantsystemametaanalysisofvariancefrommrsstudiesofglutathione
AT xuanli schizophreniaincreasesvariabilityofthecentralantioxidantsystemametaanalysisofvariancefrommrsstudiesofglutathione
AT qiangluo schizophreniaincreasesvariabilityofthecentralantioxidantsystemametaanalysisofvariancefrommrsstudiesofglutathione
AT qiangluo schizophreniaincreasesvariabilityofthecentralantioxidantsystemametaanalysisofvariancefrommrsstudiesofglutathione
_version_ 1718404808246820864